BerGenBio Secures €25 Million Capital Raise

| News

BerGenBio AS (“BerGenBio” or the “Company”) has announced that it has secured a capital raise of NOK212 million (c. $25 million) in a private placement from existing shareholders, including Investinor AS and Meteva AS.  The proceeds will be used primarily to support the ongoing clinical and commercial development of the company´s lead asset BGB324. Read more

Sarsia Seed